Myasthenia gravis
RecruitingStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
- Disease:Myasthenia gravis
- Substances:Iptacopan
Italy- Participants:18–64 years · 65+ years
- Substances:Iptacopan
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Italy213 clinical trials in Orbassano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer and mesothelioma treatments, including studies of novel therapeutic combinations and targeted therapies.
Multiple trials evaluating immunotherapy approaches and targeted molecular treatments for advanced stages of cancer.
Research initiatives investigating treatments for blood disorders and related conditions, with particular focus on innovative therapies.
Studies examining new therapeutic approaches for blood disorders and their complications.
Clinical investigations focusing on heart failure prevention and innovative cardiovascular treatments.
Trials evaluating new therapeutic approaches for reducing cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.